Results 161 to 170 of about 6,860 (236)

Retraction: Doripenem, Ertapenem, and Meropenem Sensitivity in Salmonella Typhi: A Cross-Sectional Study From Pakistan. [PDF]

Cureus
Shah MM, Khan I, Iftikhar M, Shah N, Rahman SU, Khan J.   +5 more
europepmc   +1 more source

Ceftazidime/Avibactam Monotherapy Versus Other Antibiotics: Where Do We Stand? [PDF]

Pathogens
Vougiouklakis G, Tsioutis C, Vasileiadi N, Alexakis K, Spernovasilis N, Agouridis AP.   +5 more
europepmc   +1 more source

Shifting of bla_KPC-2 to bla_KPC-90 in a sequence type 11 Klebsiella pneumoniae strain before the use of ceftazidime-avibactam. [PDF]

BMC Genomics
Hu D, Zhao Y, Mi S, Wang S, Zhang J, Luo X, Li D, Chen J, Hong G.   +8 more
europepmc   +1 more source

Antimicrobial resistance patterns and clinical outcomes in ventilator-associated pneumonia. [PDF]

Bioinformation
Krunalkumar Sharma U, Shah AD.
europepmc   +1 more source

Indoor airborne dust in veterinary facilities as a reservoir of bacterial pathogens and antimicrobial resistance. [PDF]

Front Vet Sci
Thant HPP, Kaafarani SG, Mille J, Phanitchat T, Puangseree J, Hein ST, Prathan R, Srisanga S, Chuanchuen R.   +8 more
europepmc   +1 more source

Glnk Mediates Carbapenem Resistance Through the NtrB/NtrC-OprD Regulatory Pathway in <i>Pseudomonas aeruginosa</i>. [PDF]

Pathogens
Sun X, Li Y, Gong X, Du Q, Jin Y, Cheng Z, Jin S, Wu W.   +7 more
europepmc   +1 more source

Investigation of carbapenem-hydrolysing <i>Klebsiella oxytoca</i> strains lacking detectable carbapenemase genes. [PDF]

J Med Microbiol
Teraguchi H, Oda A, Wakai S, Kawakami S, Yoshida K, Hayashi W, Kitamura N, Sugawara Y, Ohara N, Sugai M, Yahara K, Hirabayashi A.   +11 more
europepmc   +1 more source

Differing Rates of Carbapenem Resistance in Gram-Negative Bacteria Within Lower and Higher Socioeconomic Classes in Eastern India. [PDF]

Cureus
Chakraborty D, Roy T, Gangopadhyay P.
europepmc   +1 more source